Ligand validation:2V08

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2V08_IMD_A_1089	98%	74%	0.062	0.982	0.43	0.57	-	-	0	0	100%	1
2V08_IMD_B_1088	90%	64%	0.095	0.978	0.39	0.99	-	-	0	0	100%	1
2V08_IMD_B_1089	87%	72%	0.094	0.967	0.57	0.5	-	-	2	0	100%	1
2V08_IMD_A_1088	58%	63%	0.164	0.944	0.57	0.85	-	-	0	0	100%	1
3PH2_IMD_B_1088	92%	69%	0.078	0.967	0.44	0.74	-	-	0	0	100%	1
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
9FP4_IMD_A_402	100%	74%	0.036	0.993	0.23	0.76	-	-	0	0	100%	1
6THT_IMD_A_301	100%	89%	0.036	0.993	0.6	0.05	-	-	0	0	100%	1
5OKB_IMD_B_502	100%	75%	0.036	0.984	0.38	0.58	-	-	1	0	100%	1
6IJ1_IMD_A_402	100%	52%	0.036	0.984	0.55	1.27	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.